Efficacy and safety of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with pancreatic cancer peritoneal metastasis
The combination of CRS and HIPEC appears to be a viable and promising treatment modality for patients with peritoneal metastasis of pancreatic cancer, offering an improved survival rate with manageable safety concerns. Further research is needed to refine patient selection criteria and to explore the long-term benefits of this approach.
Authors
- Guojun Yan (ORCID: https://orcid.org/0000-0002-6686-0906)
- Kai Zhang (ORCID: https://orcid.org/0000-0003-2800-0531)
- Lijun Yan (ORCID: https://orcid.org/0009-0005-4740-0487)
- Yanbin Zhang (ORCID: https://orcid.org/0000-0002-6292-8352)
Institutions
- Capital Medical University (CN)
- Beijing Shijitan Hospital (CN)
Publication Details
- Journal
- World Journal of Surgical Oncology
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1186/s12957-024-03464-9
- Citations
- 6
- Primary Topic
- Intraperitoneal and Appendiceal Malignancies
- Type
- article
- Field-Weighted Citation Impact
- 3.44